Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled trial

Clinical and Experimental Allergy

Volumn 36, Issue 9, 2006, Pages 1115-1121

  Berth Jones, J ^a   Arkwright, P D ^b   Marasovic, D ^c   Savani, N ^d   Aldridge, C R ^e   Leech, S N ^f   Morgan, C ^g   Clark, S M ^h   Ogilvie, S ⁱ   Chopra, S ^j   Harper, J I ^k   Smith, C H ^l   Rook, G A W ^m   Friedmann, P S ^g  

^a GEORGE ELIOT HOSPITAL   (United Kingdom)

^b BOOTH HALL CHILDREN S HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL SPLIT   (Croatia)

^d MOUNT VERNON HOSPITAL   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^h LEEDS GENERAL INFIRMARY   (United Kingdom)

ⁱ UNIVERSITY OF DUNDEE   (United Kingdom)

^j KING GEORGE HOSPITAL   (United Kingdom)

^k GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^l ST THOMAS HOSPITAL   (United Kingdom)

^m UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Atopic dermatitis; Double blind; Hygiene hypothesis; Mycobacterium vaccae; Placebo controlled trial; Randomized; SASSAD score

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; PIMECROLIMUS; PLACEBO; STEROID; TACROLIMUS;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; IMMUNE SYSTEM; MALE; MYCOBACTERIUM; MYCOBACTERIUM VACCAE; PHOTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ECZEMA; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; MALE; MYCOBACTERIUM; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33748431182     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02558.x     Document Type: Article

References (25)

1. Akdis M, Blaser K, Akdis CA. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005; 116:961-8.
2. Robinson DS, Larche M, Durham SR. Tregs and allergic disease. J Clin Invest 2004; 114:1389-97.
3. Akbari O, Umetsu DT. Role of regulatory dendritic cells in allergy and asthma. Curr Opin Allergy Clin Immunol 2004; 4:533-8.
4. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004; 113:651-7.
5. Rook GA, Burnet LR. Microbes, immunoregulation, and the gut. Gut 2005; 54:317-20.
6. Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? Br J Dermatol 2005; 152:202-16.
7. Arkwright PD, David TD Eat dirt. The hygiene hypothesis of atopic diseases. Recent Adv Paediatr 2004, Chapter 21, 199-216.
8. Adams VC, Hunt JR, Martinelli R, Palmer R, Rook GA, Brunet LR. Mycobacterium vaccae induces a population of pulmonary CD11c+cells with regulatory potential in allergic mice. Eur J Immunol 2004; 34:631-8.
9. Barlan IB, Bahceciler N, Akdis M, Akdis CA. Role of bacillus Calmette-Guerin as an immunomodulatory for the prevention and treatment of allergy and asthma. Curr Opin Allergy Clin Immunol 2005; 5:552-7.
10. Shirakawa T, Enomoto T, Shimazu S, Hopkins JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275:77-9.
11. Obihara CC, Beyers N, Gie RP et al. Inverse association between Mycobacterium tuberculosis infection and atopic rhinitis in children. Allergy 2005; 60:1121-5.
12. Bibakis I, Zekveld C, Dimitroulis I et al. Childhood atopy and allergic disease and skin test responses to environmental mycobacteria in rural Crete: a cross-sectional survey. Clin Exp Allergy 2005; 35:624-9.
13. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001; 107:531-4.
14. Arkwright PD., David TJ Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. Br J Dermatol 2003; 149:1029-34.
15. Shirtcliffe PM, Easthope SE, Cheng S et al. The effect of delipidated deglycopilidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. Am J Respir Crit Care Med 2001; 163:1410-4.
16. Camporota L, Corkhill A, Long H et al. The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur Respir J 2003; 21:287-93.
17. Shirtcliffe PM, Easthope SE, Weatherall M, Beasley R. Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guerin in adult asthma. Clin Exp Allergy 2004; 34:207-12.
18. Williams HC, Burney PGJ, Pembroke AC, Hay RJ(on behalf of the UK Diagnostic Criteria for Atopic Dermatitis Working Party) Validation of the UK diagnostic criteria for atopic dermatitis in a population setting. Br J Dermatol 1996; 135:12-7.
19. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol 1989; 144 (Suppl.):13-4.
20. Berth-Jones J. Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 135 (Suppl. 48):25-30.
21. Lewis-Jones MS, Finlay AY. The childrens dermatology life quality index (CDLQI) - initial validation and practical use. Br J Dermatol 1995; 132:942-9.
22. Hollander M, Wolfe DA (1973); Nonparametric Statistical Methods. New York: Wiley & Sons.
23. low T-cells induced by SRP299 killed Mycobacterium vaccae. Nat Med 2002; 8:625-9.
24. Sayers I, Severn W, Scanga CB, Hudson J, Le Gros G, Harper JL. Suppression of allergic airway disease using mycobacterial lipoglycans. J Allergy Clin Immunol 2004; 114:302-9.
25. Hunt JR Martinelli R, Adams VC, Rook GAW, Rosa Brunet L. Intragastric administration og Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model. Clin Exp Allergy 2005; 35:685-90.